Together, we make a difference

Here's to 25 years of achievements, innovation, and
collaboration. Together, we continue to make a difference for patients around the world.

More on 25 years Basilea

Together, we make a difference

Here's to 25 years of achievements, innovation, and
collaboration. Together, we continue to make a difference for patients around the world.

More on 25 years Basilea

Together, we make a difference

Here's to 25 years of achievements, innovation, and
collaboration. Together, we continue to make a difference for patients around the world.

More on 25 years Basilea

We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with severe and life-threatening bacterial and fungal infections. Basilea is located in the Basel area, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).

CEO David Veitch | Half-Year Report 2025

Play

Half-Year Report 2025

Download English
Download German

Report Archive

CEO Statement

For the benefit of patients around the world, we are continuing to establish Cresemba and Zevtera as truly global brands. Based on our proven expertise in advancing anti-infectives through research and development to the market, we are aiming at becoming one of the leading companies in this space.